Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Giralt

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|February 10, 2015
Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?R Tamari, T I Mughal, D Rondelli, et al.
Leukemia|March 8, 2019
Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Bone Marrow Transplantation|January 22, 2013
Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer CenterM Pozotrigo, N Adel, H Landau, et al.
Leukemia|April 24, 2013
Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significanceD Zamarin, S M Devlin, M E Arcila, et al.
Bone Marrow Transplantation|September 18, 2002
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myelomaS Giralt, A Aleman, A Anagnostopoulos, et al.
Bone Marrow Transplantation|January 20, 2009
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndromeL De Padua Silva, M de Lima, H Kantarjian, et al.
Bone Marrow Transplantation|August 15, 2012
Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients' monitoring after transplantationD Zamarin, S Giralt, H Landau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemiaC M Seong, S Giralt, H Kantarjian, et al.
Bone Marrow Transplantation|December 1, 1996
Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantationM Körbling, P Anderlini, A Durett, et al.
Leukemia|October 3, 2003
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplantO Khorshid, E de Meis, T Martin, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|February 10, 2015
Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?R Tamari, T I Mughal, D Rondelli, et al.
Leukemia|March 8, 2019
Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Bone Marrow Transplantation|January 22, 2013
Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer CenterM Pozotrigo, N Adel, H Landau, et al.
Leukemia|April 24, 2013
Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significanceD Zamarin, S M Devlin, M E Arcila, et al.
Bone Marrow Transplantation|September 18, 2002
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myelomaS Giralt, A Aleman, A Anagnostopoulos, et al.
Bone Marrow Transplantation|January 20, 2009
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndromeL De Padua Silva, M de Lima, H Kantarjian, et al.
Bone Marrow Transplantation|August 15, 2012
Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients' monitoring after transplantationD Zamarin, S Giralt, H Landau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemiaC M Seong, S Giralt, H Kantarjian, et al.
Bone Marrow Transplantation|December 1, 1996
Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantationM Körbling, P Anderlini, A Durett, et al.
Leukemia|October 3, 2003
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplantO Khorshid, E de Meis, T Martin, et al.
Pageof 18